Biodesix (BDSX) executive compensation, 2026 proxy

Scott Hutton, President and Chief Executive Officer, was paid $2.2M in 2025, up 7% from $2.1M the year before.

Filed
April 9, 2026
Annual meeting
May 19, 2026
Pay year
2025
Named executives
3
CEO total pay
$2.2M+7% vs prior year
CEO pay in equity
39%$881,286 in awards
CEO 2025 Total Pay
$2,238,470Increased from prior year
Bonus Payout Level
110%Based on 2025 performance

How Hutton was paid

$2.2M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary29%Stock awards16%Option awards23%Non-equity incentive32%All other compensation0%

Named executive officers

ExecutiveTotal
Scott HuttonPresident and Chief Executive Officer$2,238,470
Robin Harper CowieChief Financial Officer, Secretary and Treasurer$962,001
Kieran O’KaneChief Commercial Officer$1,007,292

What changed and why

  • $2.2MScott Hutton received total compensation of $2,238,470 for fiscal 2025, compared to $2,084,873 in the prior year.
  • $589KBase salary for the CEO increased from $588,858 in 2024 to $643,404 in 2025.
  • 110%Annual cash bonus plan payouts for 2025 were approved at a 110% achievement level based on performance objectives.
  • $357KStock awards granted to the CEO totaled $356,849 and option awards totaled $524,437 for fiscal 2025.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.